Plasma bio-adrenomedullin is a marker of acute heart failure severity in patients with acute coronary syndrome

Plasma bio-adrenomedullin is a marker of acute heart failure severity in patients with acute coronary syndrome

Background: The assessment of acute heart failure (AHF) in patients with acute coronary syndrome (ACS) is challenging. This study tested whether measuring plasma adrenomedullin in patients admitted for ACS provides valuable information regarding the presence of AHF at admission or its occurrence dur...

Full description

Bibliographic Details
Main Authors:	Mattia Arrigo, Jiri Parenica, Eva Ganovska, Marie Pavlusova, Alexandre Mebazaa
Format:	Article
Language:	English
Published:	Elsevier 2019-03-01
Series:	International Journal of Cardiology: Heart & Vasculature
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906719300132

Similar Items

Plasma Clearance of Intravenously Infused Adrenomedullin in Rats with Acute Renal Failure
by: Hiroshi Hosoda, et al.
Published: (2022-09-01)

In hospital costs of acute heart failure patients in the Czech Republic
by: Ondrackova Barbora, et al.
Published: (2009-12-01)

Bioactive adrenomedullin for assessment of venous congestion in heart failure
by: Anna Egerstedt, et al.
Published: (2022-10-01)

Plasma bioactive adrenomedullin predicts outcome after acute stroke in early rehabilitation
by: Azadeh Shafieesabet, et al.
Published: (2023-03-01)

Copeptin, myeloperoxidase and pro-adrenomedullin for acute coronary syndrome in patients with chronic kidney disease
by: Jen Heng Pek, et al.
Published: (2019-09-01)

Added value of serial bio-adrenomedullin measurement in addition to lactate for the prognosis of septic patients admitted to ICU
by: Alice Blet, et al.
Published: (2020-02-01)

Adrenomedullin Is a Diagnostic and Prognostic Biomarker for Acute Intracerebral Hemorrhage
by: Francisco J. Julián-Villaverde, et al.
Published: (2021-06-01)

Increased plasma adrenomedullin in patients undergoing percutaneous transluminal coronary angioplasty
by: MK Erol
Published: (2001-01-01)

Relation between Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure and the Dose of Diuretics in 2-Year Follow-Up—Data from FAR NHL Registry
by: Monika Špinarová, et al.
Published: (2022-10-01)

Adrenomedullin is a biological marker of heart failure: review of modern literature Amina M. Alieva*1, Natalia
by: Amina M. Alieva, et al.
Published: (2022-07-01)

Novelties in the early management of acute heart failure syndromes
by: R Salem, et al.
Published: (2010-07-01)

Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis
by: Rosa Zampino, et al.
Published: (2021-01-01)

Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial
by: Koji Takagi, et al.
Published: (2021-09-01)

Prevalence and clinical significance of liver function abnormalities in patients with acute heart failure
by: Klaudia Vyskocilova, et al.
Published: (2015-09-01)

Mid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosis
by: Daniela Lopes, et al.
Published: (2017-06-01)

Plasma bioactive adrenomedullin on intensive care unit admission is associated with acute respiratory distress syndrome: an observational study
by: Patrik Johnsson, et al.
Published: (2023-03-01)

The value of plasma pro-enkephalin and adrenomedullin for the prediction of sepsis-associated acute kidney injury in critically ill patients
by: Ruijin Liu, et al.
Published: (2020-04-01)

Acute Heart Failure From Coronary Cameral Fistula
by: Raed Qarajeh, MD, et al.
Published: (2020-12-01)

Acute Heart Failure Is a Malignant Process: But We Can Induce Remission
by: Gad Cotter, et al.
Published: (2023-11-01)

Uso de levosimendana em diversos quadros de insuficiência cardíaca aguda Levosimendan use in several scenarios of acute heart failure
by: Miguel Tavares, et al.
Published: (2008-03-01)

Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure
by: Silvia Spoto, et al.
Published: (2023-07-01)

Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study
by: Alexandre Mebazaa, et al.
Published: (2018-12-01)

Heart rate – A complex prognostic marker in acute heart failure
by: Jan Olligs, et al.
Published: (2020-02-01)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
by: Christopher Geven, et al.
Published: (2018-02-01)

Clinical Characteristics and Predictors of In-Hospital Mortality among Older Patients with Acute Heart Failure
by: Giuseppe De Matteis, et al.
Published: (2022-01-01)

Coronary artery fistula as another cause of acute heart failure
by: Danay Pérez Mijenes, et al.
Published: (2023-09-01)

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study
by: Dirk van Lier, et al.
Published: (2023-01-01)

Identifying Candidate Protein Markers of Acute Kidney Injury in Acute Decompensated Heart Failure
by: Evelyn M. Templeton, et al.
Published: (2022-01-01)

Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure
by: Kirsten Thiele, et al.
Published: (2022-08-01)

Plasma thrombomodulin levels are associated with acute kidney injury in patients with acute heart failure
by: Shu-Min Lin, et al.
Published: (2022-12-01)

Efficacy of Non-Invasive Ventilation in Acute Coronary Syndrome Patients with Acute Systolic Heart Failure
by: Chao Qu, et al.
Published: (2022-09-01)

Effect of systemic corticosteroid therapy for acute heart failure patients with elevated C‐reactive protein
by: Òscar Miró, et al.
Published: (2022-08-01)

Coronary angiography in patients with acute heart failure: from the KCHF registry
by: Yuta Seko, et al.
Published: (2022-02-01)

Circulating microRNAs and Outcome in Patients with Acute Heart Failure.
by: Marie-France Seronde, et al.
Published: (2015-01-01)

Acute heart failure
by: Sénior Sánchez, Juan Manuel, et al.
Published: (2015-01-01)

Assessment of prognostic markers of heart failure following acute myocardial infarction in patients treated with primary percutaneous coronary intervention
by: Marjanović Dajana, et al.
Published: (2022-01-01)

Sex Differences in the Evaluation of Congestion Markers in Patients with Acute Heart Failure
by: Pietro Scicchitano, et al.
Published: (2022-02-01)

Sex differences in congestive markers in patients hospitalized for acute heart failure
by: Caroline Espersen, et al.
Published: (2021-06-01)

Markers of diuretic resistance in emergency department patients with acute heart failure
by: Andrew Doering, et al.
Published: (2017-05-01)

Are there differences in acute phase inflammation markers regarding the type of heart failure?
by: Jaime Agüero-Ramón-Llin, et al.
Published: (2011-09-01)